Skip to main content
MANGOCEUTICALS, INC. logo

MANGOCEUTICALS, INC. — Investor Relations & Filings

Ticker · MGRX ISIN · US56270V2051 LEI · 984500BKBD93A8A67E98 US Human health and social work activities
Filings indexed 215 across all filing types
Latest filing 2024-05-16 Annual Report
Country US United States of America
Listing US MGRX

About MANGOCEUTICALS, INC.

https://www.mangorx.com/

Mangoceuticals, Inc. is a health and wellness company that develops, markets, and sells a variety of products and services through its secure telemedicine platform, MangoRx. The company primarily focuses on men's health, offering treatments for conditions such as erectile dysfunction and providing access to oral testosterone replacement therapy. Mangoceuticals has expanded its portfolio to address the weight management and diabetes markets, offering medications including Semaglutide and Tirzepatide, as well as the patented product Diabetinol for blood sugar and weight control. The company utilizes a direct-to-consumer model to provide convenient and accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Annual Report 2024
Annual Report
2024-05-16 English
Proxy Solicitation & Information Statement 2024
Proxy Solicitation & Information Statement
2024-05-16 English
Interim / Quarterly Report 2024
Interim / Quarterly Report Q1 2024
2024-05-15 English
Registration Form 2024
Registration Form
2024-05-14 English
Regulatory Filings 2024
Regulatory Filings
2024-05-10 English
Regulatory Filings 2024
Regulatory Filings
2024-05-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.